Discover Elsevier’s open access options in Biochemistry, Genetics and Molecular Biology
We understand that swift access to quality research is vital in Biochemistry, Genetics and Molecular Biology. We also recognize that your findings have the potential to change lives, so naturally you want them to reach the widest audience possible.
Did you know that there are a range of ways you can make your work open access (OA) with Elsevier? Over the past five years, we’ve watched authors embrace the OA route in this field, leading to a 670% rise in articles published in our open access journals alone!
Why publish OA with Elsevier?
There are plenty of good reasons. We offer you:
- Choice: We have full open access Biochemistry journals and subscription journals that support open access publishing. All journals also provide a green open access option. In addition, we offer you choice when it comes to the user licenses that define how readers can reuse your OA content.
- Quality: All published articles are peer reviewed. Our journals have established reputations, high readership and many have strong CiteScores and Impact Factors.
- Integrity: All journals are indexed by Scopus and DOAJ (Directory of Open Access Journals).
- Experience: As active researchers in their fields, our journal editors bring a wealth of knowledge.
- Options to store, share, discover and reuse research data
- Support complying with policies. We have established a number of agreements with organizations such as the Wellcome Trust and Research Councils UK.
- Reach: Articles are immediately and permanently free to read and download from our publishing platform ScienceDirect. Because articles are tagged open access, the 17 million users per month can easily search, browse and set up alerts. We also support industry initiatives such as ORCID, Crossref and CHORUS
What motivates authors to choose the OA route…
Director Institute of Human Genetics, NIH-UP Manila, Philippines
“Given its reputation on professional, authentic, reliable and very scientific review process, it was really an honor for our manuscript to be part of this esteemed journal.”
University of Hohenheim, Stuttgart, Germany
“We received more than a quarter of a million euros in total in funding based on the two publications in Biotechnology Reports to continue our work”
ETH Zürich, Zürich, Switzerland
“Molecular Metabolism is a relatively new journal but it has a good impact factor and publishes high quality studies. I particularly like the journal policy about the fast review and editorial decision process.”
University of North Carolina, Chapel Hill, USA
“As a junior faculty, having this paper published puts me in a much better position to apply for funding.”
Nelson R Mandela School of Medicine, University of KwaZulu-Natal, South Africa
“The responses we are getting to our article are very positive – this could place us in a top position with our scientific findings, paving way for us to make new connections and reach new heights.”
Head of the Molecular Biology Department at the Institute of Genetics and Animal Breeding, Poland
“Not everyone has subscription access, so if you publish OA, more people see your work and then hopefully cite it. Citations are often used as a research importance indicator and can decide whether you get a new grant, or even a new job.”
Chair of Biophysics at the Medical College of Wisconsin, USA
“For me, it was wonderful that students anywhere in the world could access it. The only way to make things really stick with students is to make it easily available. Then, I noticed that lecturers at institutions were downloading the slides, so the paper has reached a new group of students through them.”
...And what our editors think about OA
Project Manager for the Oslo Cancer Cluster, Norway
“Many open access journals are still relatively new which means they aren’t yet very well known in their communities and are still building their reputation.”
Director of Clinical Toxicology and Professor of Pathology at The Johns Hopkins Hospital, USA
“I work at Johns Hopkins University School of Medicine and one of the key pillars in our institutional mission is the dissemination of knowledge...”
Scientific Director of Universitäts-Herzzentrum, and Director, Institut für Experimentelle Kardiovaskuläre Medizin, Germany
“We probably have unnecessary double work taking place in the Biosciences. I’m sure open access helps prevent that figure rising.”
Biomolecular Simulations Group Lead at Pasteur Institut in Montevideo, Uruguay
“One of the big advantages of OA is that people see the full content on the publisher’s platform.”
Scientific Director of the German Institute of Human Nutrition (DIfE) and Chair of the Department of Molecular Toxicology, DIfE/University of Potsdam, Germany
“Is OA a consideration for me when I publish? Always, always… It’s about visibility, acceptance of ideas by the wider public and citations.”
Emeritus Professor and Director of Research in the Department of Biochemistry at the University of Cambridge, UK
“We need an open policy that recognizes inequality of resources in some countries and ensures we don’t unfairly discriminate...”
Ready to publish OA with Elsevier?
You can select one of our open access Biochemistry, Genetics and Molecular Biology titles:
Or submit to one of our multidisciplinary open access titles – they all welcome Biochemistry submissions:
We also have subscription journals in Biochemistry, Genetics and Molecular Biology ready to receive your gold OA submission:
Our APC (article publishing charge) fees range between $500 and $4,150 US Dollars excluding tax, and are comparable with other publishers. Specific prices can be found on the individual journal homepages.
Find out more about...
- Open access at Elsevier
- The Creative Commons user licenses on offer.
- The agreements we have in place with institutions and funding bodies to help you comply with OA policies.
- Our approach to open access pricing. Learn how we determine APCs and why we never double dip (i.e. charge our subscribers for open access articles).
- Share Links. These personalized URLs offer 50 days’ free access to your newly published article on ScienceDirect.
- Journal finder. Smart technology that helps you identify the right home for your research. Searches can be limited to titles offering OA options.
- Navigate your research journey with Researcher Academy. Free e-learning modules developed by global experts. Career guidance and advice including on Funding and Ensuring Visibility.
Did you know?
Elsevier is a founding partner of Research4Life, which provides free or low cost research to institutions in the developing world. As well as technical and communications expertise, we have contributed more than a quarter of its nearly 79,000 peer-reviewed resources - approximately 2,500 Elsevier journals and 20,000 ebooks, as well as Scopus, Mendeley and Clinical Key, a point of care database for doctors.